SCHEMBL6412987

SCHEMBL6412987

CN(C(=O)OCc1ccccc1)[C@@H](CS)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.50
CTRB1 P17538 2/20 0.49
ITGB3 P05106 1/20 0.47
ITGA2B P08514 1/20 0.47
ALDH1A1 P00352 4/20 0.47
CTSL P07711 1/20 0.45
CTSB P07858 1/20 0.45
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45
FOLH1 Q04609 2/20 0.45
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
CPA3 P15088 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28486332 1.00 ABCB1 (0.50) ABCB1CTRB1ITGB3ITGA2BALDH1A1
SCHEMBL7454974 1.00 ABCB1 (0.50) ABCB1CTRB1ITGB3ITGA2BALDH1A1
SCHEMBL6420482 0.89 FOLH1 (0.48) ABCB1CTRB1ITGB3ITGA2BALDH1A1
SCHEMBL30278712 0.87 ABCB1 (0.51) ABCB1ITGB3ITGA2BALDH1A1CTSL
SCHEMBL2968658 0.87 ITGB3 (0.59) ABCB1CTRB1ITGB3ITGA2BALDH1A1
SCHEMBL31739224 0.87 ITGB3 (0.59) ABCB1CTRB1ITGB3ITGA2BALDH1A1
SCHEMBL8067076 0.87 ITGB3 (0.59) ABCB1CTRB1ITGB3ITGA2BALDH1A1
SCHEMBL21874257 0.87 ABCB1 (0.51) ABCB1ITGB3ITGA2BALDH1A1CTSL
SCHEMBL6370553 0.87 ABCB1 (0.51) ABCB1ITGB3ITGA2BALDH1A1CTSL
SCHEMBL2494968 0.87 ITGB3 (0.59) ABCB1CTRB1ITGB3ITGA2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161578-A1 THERAPEUTIC CONJUGATES Starpharma Pty Limited (AU) 2023-04-12 EP disclosed
EP-1313738-A4 PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS IMMUNOGEN INC (US) 2005-01-19 EP disclosed
EP-1313738-A1 PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS Immunogen, Inc. (US) 2003-05-28 EP disclosed
WO-2002016368-A1 PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS IMMUNOGEN, INC. (US) 2002-02-28 WO disclosed
US-6180611-B1 INHIBITORS OF MATRIX METALLOPROTEINASES AND TUMOR NECROSIS FACTOR DARWIN DISCOVERY, LTD. (GB) 2001-01-30 US disclosed
US-5994312-A Peptidyl compounds DARWIN DISCOVERY, LTD. (GB) 1999-11-30 US disclosed
EP-0784629-B1 PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEASES DARWIN DISCOVERY LTD (GB) 1999-04-28 EP disclosed